lunes, 6 de mayo de 2019

NIH Funding Opportunities and Notices for May 3, 2019 (The NIH Guide TOC)

national institute of biomedical imaging and bioengineering - listserv

Weekly NIH Funding Opportunities and Notices

NIH Guide for Grants and Contracts

May 03, 2019
Table of Contents (TOC)



Notices

  • Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)
    (NOT-OD-19-100)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
  • Notice of Intent to Publish a Funding Opportunity Announcement for Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
    (NOT-OD-19-104)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
  • Notice of Correction to PAR-19-246 "Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed)"
    (NOT-DA-19-033)
    National Institute on Drug Abuse
  • Notice of Informational Webinar on the NIGMS Technology Development Funding Opportunity Announcements (R21 and R01)
    (NOT-GM-19-040)
    National Institute of General Medical Sciences
  • Notice of NICHD Participation in PAR-18-822 "Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)"
    (NOT-HD-19-010)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Notice of Correction to Award Budget for RFA-HL-19-024 "Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)"
    (NOT-HL-19-698)
    National Heart, Lung, and Blood Institute
  • Notice of Correction in Expiration Date for PAR 18-331 "Simulation Modeling and Systems Science to Address Health Disparities (R01Clinical Trial Not Allowed)"
    (NOT-MD-19-022)
    National Institute on Minority Health and Health Disparities
    National Institute of Mental Health
  • Notice of Change to Key Dates in RFA-RM-19-005 " NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)"
    (NOT-RM-19-007)
    Office of Strategic Coordination (Common Fund)
  • Notice of Change to Eligibility Requirements to the International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
    (NOT-TW-19-004)
    John E. Fogarty International Center

Requests for Applications

  • HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) (RFA-AI-19-041)
    National Institute of Allergy and Infectious Diseases
    National Cancer Institute
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): September 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • HLA and KIR Region Genomics in Immune-Mediated Diseases (U19 Clinical Trial Not Allowed) (RFA-AI-19-044)
    National Institute of Allergy and Infectious Diseases
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): September 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required)
    (RFA-AI-19-045)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date listed below.
  • SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed) (RFA-ES-19-009) National Institute of Environmental Health Sciences Application Receipt Date(s): July 31,2019
  • National Project to Support and Promote Consistent Implementation of the Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption (U18)
    (RFA-FD-19-023)
    Food and Drug Administration
    Application Receipt Date(s): July 10, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.

Program Announcements

  • Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
    (PAR-19-262)
    National Institutes of Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute of Allergy and Infectious Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): August 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Biological Testing Facility Access For Contraceptive Development (X01 Clinical Trial Not Allowed) (PAR-19-263)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt/Submission Date(s): July 1, 2019, December 16, 2019, May 1, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional)
    (PAR-19-264)
    National Cancer Institute
    Application Receipt/Submission Date(s): July 10, 2019; December 10, 2019; July 10, 2020; December 10, 2020; July 9, 2021; December 10, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
    (PAR-19-265)
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt/Submission Date(s): Standard dates apply by 5:00 PM local time of applicant organization. by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
  • Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
    (PAR-19-266)
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt/Submission Date(s): Standard dates apply by 5:00 PM local time of applicant organization.
  • HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
    (PAR-19-267)
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    National Institute of Mental Health
    Application Receipt/Submission Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  • Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)
    (PAR-19-268)
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt/Submission Date(s): Only accepting applications for the AIDS Application Due Date listed below. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

No hay comentarios: